Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Target pressures in glaucoma.

T Zeyen1

  • 1AZ Middelheim, Oogheelkunde, Antwerp.

Bulletin De La Societe Belge D'Ophtalmologie
|February 12, 2000
PubMed
Summary
This summary is machine-generated.

Lowering intraocular pressure is the sole treatment for glaucoma. A personalized "target pressure" formula considers maximum pressure and future damage risk, requiring periodic re-evaluation for effective glaucoma management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.

Journal of neuro-oncology·2023
Same author

The effect of phacoemulsification and combined phaco/glaucoma procedures on the intraocular pressure in open-angle glaucoma. A review of the literature.

Bulletin de la Societe belge d'ophtalmologie·2012
Same author

Anterior segment ischemia with rubeosis iridis after a circular buckling operation treated successfully with an intravitreal bevacizumab injection: a case report and review of the literature.

Bulletin de la Societe belge d'ophtalmologie·2012
Same author

Paper retracted from BSBO 316. "What do we know about trachoma in the economically weakest infantile population of Kara in Togo?".

Bulletin de la Societe belge d'ophtalmologie·2011
Same author

Patient-reported outcomes (PRO's) in glaucoma: a systematic review.

Eye (London, England)·2011
Same author

Appraisal of optic disc stereo photos pre- and post-training session.

Bulletin de la Societe belge d'ophtalmologie·2011
Same journal

Didactic image poppers maculopathy.

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Marcus Gunn Syndrome. Study of 3 rare cases].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Ocular manifestations of children living with HIV/AIDS in Kinshasa].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Management of rhegmatogenous retinal detachment with unseen breaks: about 50 cases].

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

Long term IOP lowering efficacy of bimatoprost/timolol fixed combination: a 12 month prospective study.

Bulletin de la Societe belge d'ophtalmologie·2014
Same journal

[Palpebral pilomatricoma simulating a chalazion in a young adult].

Bulletin de la Societe belge d'ophtalmologie·2014
See all related articles

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Glaucoma Research

Background:

  • Neuro-protection shows promise, but lowering intraocular pressure remains the primary glaucoma treatment.
  • Glaucoma management requires individualized treatment strategies.

Purpose of the Study:

  • To introduce a formula for calculating patient-specific target intraocular pressure.
  • To emphasize the dynamic nature of glaucoma treatment, necessitating periodic re-evaluation.

Main Methods:

  • A formula is proposed to determine target intraocular pressure.
  • The formula incorporates the presumed pressure of glaucomatous damage (maximum pressure) and future risk.

Main Results:

  • A method for calculating individualized target intraocular pressure is presented.

Related Experiment Videos

  • The importance of dynamic treatment adjustments based on risk assessment is highlighted.

    • Conclusions:

    • Calculating a personalized target intraocular pressure is crucial for effective glaucoma management.
    • Periodic re-evaluation of target intraocular pressure is essential due to varying patient needs and risks.